Sysmex Corp - Company Profile
Powered by 
All the sales intelligence you need on Sysmex Corp in one solution.
- Save hours of research time with a comprehensive
Sales Intelligence Solution.
- Understand how Sysmex Corp fits into your total
addressable market and Ideal Customer Profile.
- Gain competitive edge with triggers that tell you
when and how to engage with Sysmex Corp.
Get in touch about GlobalData Company reports
Contact the team or request a demo to find out how our data can drive your business forward
Related keylists
Sysmex Corp (Sysmex) is a provider of medical devices that researches, develops, manufactures and sells instruments, reagents, and software applications that facilitate health checkups, treatment and disease management. It offers diagnostic instruments, reagents and laboratory information systems to clinical laboratories for testing. The company’s offerings include haematology, haemostasis, and urinalysis analyzers. The company offers its products to medical institutions, research institutions, universities, national and other public hospitals. It conducts research and development at its facilities in Japan, France, New Zealand, Germany and the US. The company operates along with its subsidiaries in the Americas, Europe, the Middle East, Africa and Asia Pacific. Sysmex is headquartered in Hyogo, Japan.
Sysmex Corp premium industry data and analytics
Products and Services
| Products | Services | Brands |
|---|---|---|
| In Vitro Diagnostic Instruments, Reagents, and Software Solutions | After-Sales Services | Sysmex |
| Caresphere | Medical Services | |
| Automated Urine Particle Analyzers | ||
| XYZ | ||
| XYZ | ||
| XYZ |
History
History section provides information on new products, mergers, acquisitions, expansions, approvals, and many more key events.
| Year | Event | Description |
|---|---|---|
| 2026 | Plans/Strategy | In July, the company announced plans to introduce HISCL ADAMTS13 Activity Reagent. |
| 2026 | Contracts/Agreements | In June, the company signed a partnership with VolitionRx Limited to improve Volition's Nu.Q NETs H3.1 assay on the Sysmex platform. |
| 2026 | Acquisitions/Mergers/Takeovers | In April, the company acquired JEOL Ltd.'s clinical chemistry testing business. |
Competitor Comparison
| Key Parameters | Sysmex Corp | Becton Dickinson and Co | bioMerieux SA | Bio-Rad Laboratories Inc | Alere Inc |
|---|---|---|---|---|---|
| Headquarters | Japan | United States of America | France | United States of America | United States of America |
| City | Kobe | Franklin Lakes | Craponne | Hercules | Waltham |
| State/Province | Hyogo | New Jersey | Rhone Alpes | California | Massachusetts |
| No. of Employees | 10,861 | 72,000 | 15,226 | 7,450 | - |
| Entity Type | Public | Public | Public | Public | Private |
Key Financial Charts
Sales Growth
Net Income Growth
Executives
| Name | Position | Board | Since | Age |
|---|---|---|---|---|
| Hisashi Ietsugu | Chief Executive Officer; Chairman | Executive Board | 2023 | 77 |
| Kensuke Iizuka | Chief Financial Officer; Director; Managing Executive Officer | Executive Board | 2026 | 56 |
| Tomokazu Yoshida | Chief Technology Officer; Managing Executive Officer; Director | Executive Board | 2023 | 62 |
| Iwane Matsui | Director; President; Executive Officer | Executive Board | 2026 | 65 |
| Takashi Ono | Director; Managing Executive Officer | Executive Board | 2023 | 61 |
| Non Dignissim Eros | Proin vel | Convallis | 2026 | XY |
| Non Dignissim Eros | Proin vel | Convallis | 2026 | XY |
| Non Dignissim Eros | Proin vel | Convallis | 2026 | XY |
Have you found what you were looking for? From start-ups to market leaders, uncover what they do and how they do it.
Access more premium companies when you subscribe to Explorer